Putting developing country perspectives at the forefront of policy-making and promoting health sector and immunisation best practice
Gavi's business model is built on the principle of empowering developing countries to take the lead in initiating proposals for support, managing development grants and, ultimately, financing their own immunisation programmes.
Developing country members are therefore a key constituency within the Vaccine Alliance, especially on the Board and its various policy-making committees, where five members, usually health ministers, represent all 56 countries eligible for Gavi support.
It is the Board members' task to gather views from their peers to ensure that developing countries' needs and perspectives on immunisation remain at the forefront of Gavi policy-making and priorities.
Keeping immunisation on developing countries' agendas
Role on the Gavi Board
The Gavi Board has five members from developing country governments, currently represented by Chad, Nicaragua, Bolivia, Uganda, Bangladesh, Afghanistan and Djibouti.
A dozen other developing country governments have served on Gavi's Board since the partnership started in 2000. Nicaragua represents developing country governments on Gavi's Executive Committee.
Developing country Board members feed knowledge and best practice back to their regional constituencies, helping to spread the word about the value of vaccination and steadily increase global levels of immunisation coverage.
They update countries with immunisation information through written communications and regional or global forums, and help to keep health sector development and immunisation on the national agendas of member states.
In this role, developing countries have been strong supporters of Gavi's health system strengthening as a means to tackle bottlenecks holding back immunisation.
Growing support for co-financing
The growing support for the co-financing of vaccines among developing countries is essential to the long-term sustainability of immunisation programmes that Gavi supports.
Guyana took the lead in 2009 by becoming the first country to graduate from Gavi support and underwrite the full cost of introducing pentavalent vaccine. In 2011, 62 countries co-financed Gavi vaccines. Seven highly committed countries are co-financing ahead of the required starting date to progress faster towards financial sustainability: Benin, Mongolia, Papua New Guinea, Senegal, Togo, Yemen and Zambia.